Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.

Also called NCT04184635

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04184635
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04184635. Randomized; no masking; primary purpose treatment. Start 2021-10-14 (actual); primary completion 2026-10-14 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock
Acronym
ANCHOR
Condition
Acute Myocardial Infarction
Condition
Cardiogenic Shock
Intervention (Device)
VA-ECMO
Lead sponsor
Assistance Publique - Hôpitaux de Paris (class: other)

Record details

Record id
cardio:ct-nct04184635
Content hash
6fa0d040bfb978876f7bcbb74787f6a0e273247f04e40b55864309bd058c60f9